Learn more about how FLULAVAL QUADRIVALENT can help protect all your recommended patients from influenza.
FLULAVAL QUADRIVALENT: Indicated for Ages 6 Months +
Same 0.5-mL Dose Indicated for Ages 6 Months +
Information on Fever in Pediatric Patients at 0.5-mL Dose
FLULAVAL QUADRIVALENT: Dosing and Administration
FLULAVAL and FLUARIX are registered trademarks of the GSK group of companies.
FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLULAVAL QUADRIVALENT is approved for use in persons aged 6 months and older.